7-溴-4-氯喹唑啉，CAS 登记号 573675-55-5，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 7-溴-4-氯喹唑啉 的 CAS 号：573675-55-5，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
7-Bromo-4-chloroquinazoline · CAS 573675-55-5 · C8H4BrClN2. UNII Z316120002.
| CAS Registry Number | 573675-55-5 |
|---|---|
| PubChem CID | 16780855 |
| Molecular formula | C8H4BrClN2 |
| IUPAC name | 7-bromo-4-chloroquinazoline |
| UNII (FDA) | Z316120002 |
| Molecular Weight | 243.49 |
|---|---|
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 241.92464 |
| Monoisotopic Mass | 241.92464 |
| Topological Polar Surface Area | 25.8 |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Reported hazard statements | H301 (25%), H302, H312, H332 (25%), H315 (75%), H319 (75%), H335 (75%) |
|---|
H301 (25%): Toxic if swallowed [Danger Acute toxicity, oral]
H302+H312+H332 (25%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
7-bromo-4-chloroquinazoline; 573675-55-5; DTXSID10588389; RefChem:310435; DTXCID50539153; 826-578-1; 7-bromo-4-chloro-quinazoline; MFCD06657216; QUINAZOLINE, 7-BROMO-4-CHLORO-; 4-CHLORO-7-BROMOQUINAZOLINE; 7-Bromo-4-chloro-quizoline; SCHEMBL858150; 7-BroMo-4-chloroquinazoli...; SCHEMBL27863147; SCHEMBL31236169; VLZJBXYXSWZAJQ-UHFFFAOYSA-N
CAS 573675-55-5; molecular formula C8H4BrClN2; molecular weight — g/mol.
7-bromo-4-chloroquinazoline, 573675-55-5, DTXSID10588389, RefChem:310435, DTXCID50539153, 826-578-1.
Hazard statements reported: H301, H302, H312, H332, H315.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.